4 ms·
It would have been more helpful to pull sales as well. Indomethicin is an old drug without much use and then narrow it down to suppositories it’s an even small
by refurb 5y ago
It would have been more helpful to pull sales as well.
Indomethicin is an old drug without much use and then narrow it down to suppositories it’s an even smaller market. Plus there are a dozen plus alternatives you could use.
Think of like producing a microprocessor design from 1970 where alternatives exist. Super niche. Demand is maybe 100 units per year. What would you charge?
- Luc 5y agoDepends on what competitors are charging, right? In this case it seems to indicate market failure.
- ncallaway 5y agoAre competitors charging for the product, or is it covered under patent? I don't know the market, but it appears that it may be patented until 2030 (https://www.pharmacompass.com/patent-expiry-expiration/indomethacin https://www.pharmacompass.com/patent-expiry-expiration/indom...). That being said, drug patents are complicated, and there might be competitors for this drug.
- s1artibartfast 5y agoThe original drug was approved in 1965[1], and there are more than a hundred competitors[2], and the average price is somewhere around $2/day [3]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017814s044lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/01... https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=indomethacin https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=a... https://clincalc.com/DrugStats/Drugs/Indomethacin https://clincalc.com/DrugStats/Drugs/Indomethacin
- ordinaryradical 5y agoHere’s another way of looking at it: if you need to use this obscure medicine rather than the alternatives because your condition is comparatively rarer, is it just that you should have to pay through the nose for it? Take it to the extreme: you have a very, very rare life-threatening illness. Since only 20 or so people a year are diagnosed with this, the drugs to treat it would have to cost 1.5MM just to be decently profitable. Is that a just healthcare system? A kind of inverted lottery in which the “luckier” you are the more likely to go bankrupt. One might reasonably conclude that trying to run the entirety of the healthcare system as a capitalist enterprise is perverse and trades the misery of the many for the profit of a few. In such cases, we should rightly consider all possible alternatives.
- mchusma 5y ago1 main point to this: true "insurance" could reasonably cover edge cases, including frankly some insurance covered by the state. The US "insurance" market is not really that, it's a price negotiator/health care provider/strange thing that honestly doesn't resemble any other "insurance" product. Even though we use some terms that resemble capitalism, health care is in no way a capitalist market. It's a different beast.
- s1artibartfast 5y agoThis isn't a hypothetical. There are numerous rare diseases which cost several million per year. Spinal muscular atrophy (SMA) is a prime example. Costs are typically socialized by the federal government.
- bushbaba 5y agoThis is what health “insurance” is supposed to cover. Where people pay a monthly premium to cover the small chance of a horrible disease. Instead people view health “insurance” as a healthcare plan. Which is not how the us system was designed. For those with health insurance the idea would be it cover the 10k+ per pill cost for your rare disorder.
- ChrisLomont 5y ago>Since only 20 or so people a year are diagnosed with this, the drugs to treat it would have to cost 1.5MM just to be decently profitable... Is that a just healthcare system? If it cost 1 trillion to add a year to the life of just one person, should society pay it, even if that trillion is then not able to be used for lots of other societal needs? Arguing for policy while ignoring opportunity costs leads to more human suffering than would otherwise result.
- falcolas 5y ago> Demand is maybe 100 units per year. What would you charge? Perhaps capitalism is not the best strategy to apply to healthcare. Folks in need of healthcare will always be a minority - a niche market - after all. The most prolific diseases typically only have 3-6M cases at any given time in the US. Should a person go destitute to pay for their care, just so some company's supply/demand curve is properly fitted?
- mchusma 5y agoJust to be clear, the American health care system is in no way "capitalist". It just has some of the trappings of capitalism. (There are so many examples of this, including for this case that Medicare/Medicaid are government programs where they pay whatever the drug companies ask.)
- falcolas 5y agoThe pharmaceutical market - specifically this company who is charging $10,000 for a medication in one market and under $200 in another - is certainly following capitalist methodologies: "Charge what the market can bear."
- refurb 5y agoSo you’re saying someone who is producing a niche product a minimal units should be forced to charge a low price? Regardless what their cost of goods is?
- Spivak 5y agoThat's almost never what people arguing for government intervention in healthcare pricing actually want. They want an affordable price at the point of sale to the patient while the government uses tax dollars to and fees collected at the pharmacy to smooth out prices and have standing buy orders so that medications are always available to people that need them. i.e. don't let the supply chains fall over and provide "insurance" for everyone. This really isn't that crazy in the grand scheme of things. The US right now today does basically this with dairy products.
- vidarh 5y agoThat doesn't explain why it's available cheaply in other countries, even privately. E.g. in the UK a quick check shows me I can buy a pack privately online for $40. (UK online pharmacies can sell a number of prescription-only drugs privately if they have a doctor carry out an online consultation, which means you basically fill in a form and a doctor will look at your answers and provide a prescription as part of the sales process, or you can send them a prescription you already have).
- s1artibartfast 5y agoSales are around $2 mil/year for oral and suppository combined [1]. For that you have regulatory upkeep, cost of manufacturing, and legal liability. It seems pretty clear why several of the past owners of the brand have gone bankrupts or sold off the product line. https://s28.q4cdn.com/742207512/files/doc_presentations/2021/10/Assertio-Holdings-Investor-Presentation-LD-Micro.pdf https://s28.q4cdn.com/742207512/files/doc_presentations/2021...